NIGMS maintains a diverse biomedical research portfolio, supporting a wide range of topics and investigators. In Fiscal Year (FY) 2021, NIGMS received a congressional appropriation of $2,991,417,000. As part of the Consolidated Appropriations Act, 2022, this budget increased by 3.4% to $3,092,373,000 for FY 2022. The majority of these funds support research project grants (RPGs) at research institutions throughout the country. In alignment with its commitment to transparency, NIGMS publishes data on annual trends in its grants portfolio. In this post, we first describe investigator-level trends for RPGs, then review the trends associated with competing RPGs, and lastly examine trends in the Institute’s Maximizing Investigators’ Research Award (MIRA) program.Continue reading “Application and Funding Trends in Fiscal Year 2021”
We recently reissued the funding opportunity announcement (FOA) for the Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (PAR-20-117). The first application due date is October 2, 2020.
We’re hosting a webinar to discuss this FOA and to answer your questions about the program on Thursday, August 6, 1:00-2:30 p.m. ET. To access the webinar, visit the WebEx meeting page (link no longer available). We plan to post the archived webinar and slides on the MIRA webpage after the event.Continue reading “Webinar and Other Resources for New MIRA ESI Funding Opportunity”
One of the most common questions we receive about the Maximizing Investigators’ Research Award (MIRA) program is the likelihood of an application’s funding given a certain overall impact score.
Frequent readers of this blog may note that we typically provide statistics as they relate to our R01 portfolio, but we’ve yet to provide a similar “funding curve” for the MIRA program. One reason that MIRA applications haven’t been included in these analyses is that, unlike most R01 applications, MIRA R35 applications don’t receive a percentile score. The percentile score allows for normalization of overall impact scores across study sections to account for any differences in scoring behavior that are observed in review panels. See the Office of Extramural Research’s comprehensive blog post for more information about overall impact scores and percentiles.Continue reading “Funding Trends: MIRA Applications and Overall Impact Scores”
Ninety percent of the applications to our Maximizing Investigators’ Research Award for Early Stage Investigators (known as the ESI MIRA program) that were submitted in October are about to undergo peer review. The remaining 10% were administratively withdrawn, mostly because the research proposed fell outside the NIGMS mission. This is comparable to the proportion that was withdrawn over the past 3 years.
Withdrawn applications represent a lot of wasted time and effort on the part of affected PIs and are the source of considerable frustration. So what can you do to minimize the chance of this happening to your ESI MIRA application in the future?Continue reading “How do I know if my work fits in the mission of NIGMS?”
We’ve issued a funding opportunity announcement (FOA) PAR-19-367 to maintain continued support of our Maximizing Investigators’ Research Award (MIRA) program. Under this new FOA, investigators with an active NIGMS R35 grant (both early-stage and established investigator MIRA) can submit renewal MIRA applications, and investigators with a single-PI R01-equivalent NIGMS award (DP1, DP2, R01, R37, SC1) can submit new MIRA applications.Continue reading “NIGMS Continues Its MIRA Program”